Tau phosphorylation in Alzheimer’s disease


The two predominant pathological concomitants of Alzheimer’s disease (AD) are senile plaques and neurofibrillary tangles. Although many biochemical studies have addressed the composition and formation of these AD hallmarks, very little is known about the interrelationship between the two. Here we present evidence that the tau phosphorylation characteristic of neurofibrillary tangles may be mediated by a physical association of MKK6 (mitogen-associated protein kinase kinase 6) with tau and subsequent phosphorylation of tau by the MKK6 substrate, p38 MAPK; and that APP (β-amyloid precursor protein) may be co-immunoprecipitated both with MKK6 and its upstream MAPKKK, ASK1. Taken together with recent data demonstrating APP dimerization by β-amyloid peptide (Aβ) (Lu et al., 2003), and the possible activation of ASK1 via APP dimerization (Hashimoto et al., 2003), these results suggest a model of AD in which Aβ peptide dimerizes APP directly, leading to the activation of ASK1, MKK6, and p38, with subsequent phosphorylation of tau at sites characteristic of AD.

DOI: 10.1385/NMM:5:3:205

8 Figures and Tables

Cite this paper

@article{Peel2007TauPI, title={Tau phosphorylation in Alzheimer’s disease}, author={Alyson L. Peel and Noah Sorscher and Joseph Y. Kim and Ver{\'o}nica Galv{\'a}n and Sylvia F Chen and Dale E. Bredesen}, journal={NeuroMolecular Medicine}, year={2007}, volume={5}, pages={205-218} }